Drugs & Aging

Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
pp. 273-293(21)
Authors: Díaz-Borjón, Alejandro

Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration: What is the Evidence?
pp. 295-320(26)
Authors: Ziemssen, Focke; Grisanti, Salvatore; >Karl Ulrich Bartz-Schmidt,; Spitzer, Martin S.

Memantine in Moderately-Severe-to-Severe Alzheimer's Disease: A Postmarketing Surveillance Study
pp. 321-332(12)
Authors: Clerici, Francesca; Vanacore, Nicola; Elia, Antonietta; Spila-Alegiani, Stefania; Pomati, Simone; >Roberto Da Cas,; Raschetti, Roberto; Mariani, Claudio

Is Covert Medication in Norwegian Nursing Homes Still a Problem?: A Cross-Sectional Study
pp. 333-344(12)
Authors: Kirkevold, Øyvind; Engedal, Knut

Polypharmacy among Disabled Taiwanese Elderly: A Longitudinal Observational Study
pp. 345-354(10)
Authors: Chan, Ding-Cheng Derrick; Hao, Yi-Ting; Wu, Shwu-Chong

Risedronate on Two Consecutive Days per Month
pp. 355-362(8)
Author: Frampton, James E.